Log in to save to my catalogue

Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_01152847v1

Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

About this item

Full title

Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2015-05, Vol.372 (20), p.1909-1919

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

TAS-102, a combination of trifluridine and tipiracil in which tipiracil interferes with the deactivation of trifluridine, improved overall and progression-free survival in patients whose disease had progressed after treatment with fluorouracil-containing drug combinations.
Fluoropyrimidines have long represented the cornerstone of treatment for...

Alternative Titles

Full title

Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_01152847v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_01152847v1

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1414325

How to access this item